Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systematic review on the use of biologics in adult-onset still's disease.
Fautrel B, Patterson J, Bowe C, Arber M, Glanville J, Mealing S, Canon-Garcia V, Fagerhed L, Rabijns H, Giacomelli R. Fautrel B, et al. Semin Arthritis Rheum. 2023 Feb;58:152139. doi: 10.1016/j.semarthrit.2022.152139. Epub 2022 Nov 17. Semin Arthritis Rheum. 2023. PMID: 36442231 Free article. Review.
Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease.
Topping J, Chang L, Nadat F, Poulter JA, Ibbotson A, Lara-Reyna S, Watson CM, Carter C, Pournara LP, Zernicke J, Ross RL, Cargo C, Lyons PA, Smith KGC, Del Galdo F, Rech J, Fautrel B, Feist E, McDermott MF, Savic S; ImmunAID Consortium. Topping J, et al. Among authors: fautrel b. Arthritis Rheumatol. 2024 Nov 4. doi: 10.1002/art.43054. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 39492681
Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis.
Gwinnutt JM, Norton S, Hyrich KL, Lunt M, Combe B, Rincheval N, Ruyssen-Witrand A, Fautrel B, McWilliams DF, Walsh DA, Nikiphorou E, Kiely PDW, Young A, Chipping JR, MacGregor A, Verstappen SMM. Gwinnutt JM, et al. Among authors: fautrel b. Arthritis Care Res (Hoboken). 2023 May;75(5):1026-1035. doi: 10.1002/acr.24996. Epub 2022 Dec 28. Arthritis Care Res (Hoboken). 2023. PMID: 36576238 Free PMC article.
PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis.
Bouhnik Y, Fautrel B, Beaugerie L, Pelletier AL, Martinez-Vinson C, Freudensprung U, Brigui A, Addison J. Bouhnik Y, et al. Among authors: fautrel b. Therap Adv Gastroenterol. 2023 Mar 15;16:17562848221145654. doi: 10.1177/17562848221145654. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 36936799 Free PMC article.
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.
Bourguiba R, Kyheng M, Koné-Paut I, Rouzaud D, Avouac J, Devaux M, Abdallah NA, Fautrel B, Ferreira-Maldent N, Langlois V, Ledoult E, Nielly H, Queyrel V, Sellam J, Tieulie N, Chazerain P, Evon P, Labreuche J, Savey L, Hentgen V, Grateau G, Georgin-Lavialle S; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Bourguiba R, et al. Among authors: fautrel b. RMD Open. 2022 May;8(1):e002063. doi: 10.1136/rmdopen-2021-002063. RMD Open. 2022. PMID: 35537796 Free PMC article.
Building a composite score for patient self-report of flare in osteoarthritis: a comparison of methods with the Flare-OA-16 questionnaire.
Queiroga F, Epstein J, Erpelding ML, Soudant M, King L, Spitz E, Maillefert JF, Fautrel B, Callahan LF, March L, Hunter DJ, Guillemin F. Queiroga F, et al. Among authors: fautrel b. J Clin Epidemiol. 2024 Oct;174:111467. doi: 10.1016/j.jclinepi.2024.111467. Epub 2024 Jul 26. J Clin Epidemiol. 2024. PMID: 39067540 Free article.
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Fautrel B, Bouhnik Y, Salliot C, Carbonnel F, Fumery M, Bernardeau C, Maugars Y, Flamant M, Coury F, Braithwaite B, Hateb S, Addison J; PERFUSE investigators. Fautrel B, et al. Drugs Real World Outcomes. 2025 Jan 16. doi: 10.1007/s40801-024-00477-4. Online ahead of print. Drugs Real World Outcomes. 2025. PMID: 39821191 No abstract available.
407 results